Inventor · disambiguated record
Michael A. Plotkin
Also filed as: PLOTKIN MICHAEL · PLOTKIN MICHAEL A · PLOTKIN MICHAEL AARON
3 granted patents·7 pending applications·3 citations·filing 2010–2022
50Inventor score
Files withMERCK SHARP & DOHME LLC3DUFFY JOSEPH L2ARMACOST KIRA A1BERGER RICHARD1BRICKNER STEVEN JOSEPH1
Top patents by PatentIndex Score
10 records- 0169US8742110B2Spiroxazolidinone compoundsDUFFY JOSEPH L·Filed 2011·Granted Jun 3, 2014·3 cites·15 claims
- 0259US2025051341A1Pyrazolopyrimidine derivatives and methods of use thereof for the treatment of herpesvirusesMERCK SHARP & DOHME LLC·Filed 2022·Application pending·0 cites
- 0356US2024083910A1Amido-substituted pyridyl compounds and methods of use thereof for the treatment of herpesvirusesBERGER RICHARD·Filed 2021·Application pending·0 cites
- 0455US2024018145A1Polycyclic cap-dependent endonuclease inhibitors for treating or preventing influenzaMERCK SHARP & DOHME LLC·Filed 2021·Application pending·0 cites
- 0554US2024067657A1Amido-substituted pyridyl compounds and methods of use thereof for the treatment of herpesvirusesARMACOST KIRA A·Filed 2021·Application pending·0 cites
- 0652US12497405B2Bicyclic heterocycle compounds methods of use thereof for the treatment of herpes virusesMERCK SHARP & DOHME LLC·Filed 2020·Granted Dec 16, 2025·0 cites·18 claims
- 0748US2011092480A1Substituted Heterocyclic Derivatives and Their Pharmaceutical Use and CompositionsPFIZER·Filed 2010·Application pending·0 cites
- 0846US2012065188A1Substituted heterocyclic derivatives and their pharmaceutical use and compositionsBRICKNER STEVEN JOSEPH·Filed 2011·Application pending·0 cites
- 0942US9708270B2Substituted spiropiperidinyl compounds useful as GPR120 agonistsMERCK SHARP & DOHME·Filed 2013·Granted Jul 18, 2017·0 cites·10 claims
- 1031US2013040978A1Spiro isoxazoline compounds as sstr5 antagonistsDUFFY JOSEPH L·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Michael A. Plotkin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →